HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â04¿ù19ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-04-19 17:18:24
´º½ºÈ¨ > µ¿Á¤
2015³â06¿ù29ÀÏ 17½Ã21ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
±¹¸³¾Ï¼¾ÅÍ ±¹Á¦¾Ï´ëÇпø´ëÇб³, ¾ÏÇÐȸ Çмú´ëȸ 3°³»ó µ¿½Ã ¼ö»ó

»çÁø) ¿ÞÂʺÎÅÍ ±èÇбÕ, Ãֱͼ±, ÀüÀç°ü ±³¼ö
±¹¸³¾Ï¼¾ÅÍ ±¹Á¦¾Ï´ëÇпø´ëÇб³ ½Ã½ºÅÛÁ¾¾ç»ý¹°Çаú ±èÇбÕ, ¾Ï°ü¸®Á¤Ã¥Çаú Ãֱͼ±, ÀüÀç°ü ±³¼ö°¡ Áö³­ 19ÀÏ ¼­¿ï ¼Ò°øµ¿ ·Ôµ¥È£ÅÚ¿¡¼­ °³ÃÖµÈ ‘Á¦41Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ’¿¡¼­ °¢°¢ ±âÃÊ¿ì¼ö³í¹®»ó/±¤µ¿Çмú»óÀ» ¼ö»óÇß´Ù°í ¹àÇû´Ù.

½Ã½ºÅÛÁ¾¾ç»ý¹°Çаú ±èÇÐ±Õ ±³¼ö´Â Ç×¾ÏÈĺ¸¹°ÁúÀÇ È¿´ÉÀ» ±¹³» È£¹ß¾ÏÀÎ À§¾Ï/°£¾Ï µ¿¹°¸ðµ¨¿¡¼­ Æò°¡ÇÏ´Â ¹æ¹ý·Ð¿¡ ´ëÇÑ "Preclinical Efficacy Testing for Stomach and Liver Cancers" ´ëÇѾÏÇÐȸÁö ³í¹®À¸·Î ±âÃÊ¿ì¼ö³í¹®»óÀ» ¼ö»óÇß´Ù.

¾Ï°ü¸®Á¤Ã¥Çаú Ãֱͼ± ±³¼ö´Â ¿ì¸®³ª¶ó¿¡¼­ °£¾Ï ¹ß»ý °íÀ§Ç豺À» ´ë»óÀ¸·Î ÇÏ´Â °£¾Ï °ËÁøÀÇ ºñ¿ë-È¿°ú¼ºÀ» Æò°¡ÇÏ°í, °¡Àå ºñ¿ë-È¿°úÀûÀÎ °ËÁøÀü·«¿¡ ´ëÇÑ “Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea”´ëÇѾÏÇÐȸÁö ³í¹®À¸·Î ±âÃÊ¿ì¼ö³í¹®»óÀ» ¼ö»óÇß´Ù.

¾Ï°ü¸®Á¤Ã¥Çаú ÀüÀç°ü ±³¼ö´Â ´ëÇѾÏÇÐȸÁöÀÇ ±¹Á¦È­¿¡ ±â¿©ÇÑ °ø·Î¸¦ ÀÎÁ¤¹Þ¾Æ ±Ý¹ø Çмú´ëȸ¿¡¼­ ±¤µ¿Çмú»óÀ» ¼ö»óÇß´Ù.

´ëÇѾÏÇÐȸ´Â 1958³â ´ëÇѾϿ¬±¸È¸·Î ⸳µÈ ÀÌÈÄ ±âÃÊÀû ¾Ï ¿¬±¸¿Í ÀÓ»óÀû ¿¬±¸ÀÇ ±ÕÇüÀ» ¸ÂÃß¾î ±¹³» ¾Ï ¿¬±¸ ¹× ÇмúÈ°µ¿ÀÇ È°¼ºÈ­¿¡ ¾ÕÀå¼­ ¿ÔÀ¸¸ç, ´ëÇѾÏÇÐȸÁö´Â 1973³â ´ëÇѾϿ¬±¸È¸ ÀâÁö¸¦ ½ÃÀÛÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹ß°£µÅ ÇöÀç SCIE¿¡ µîÀçµÇ´Â ±¹Á¦ÀûÀÎ ¿µ¹®ÇмúÁöÀÎ “Cancer Research and Treatment”·Î ¹ß°£µÇ°í ÀÖ´Ù.

´ëÇѾÏÇÐȸ Çмú´ëȸ´Â Áö³­ 1³â µ¿¾È ´ëÇѾÏÇÐȸÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß ¿ì¼ö ³í¹®À» ¼±Á¤ÇØ »óÀ» ¼ö¿©ÇÏ°í ÀÖ´Ù.

 

 

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bktimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
µ¿Á¤¼½¼Ç ¸ñ·ÏÀ¸·Î
¹é»óÈ« ±³¼ö, '±¹Á¦½ÉÀåÇÐ...
´ëÇÑÀ忬±¸ÇÐȸ ¸í½ÂÀç ȸ...
±Ç¼øÂù ±³¼ö ½Å°æ¿Ü°úÇÐȸ ...
¼­¿ï¹éº´¿ø ±èÁø±¸ ±³¼ö, ...
½ÅÈ«ÁÖ ±³¼ö, ¡®¼¼°èÁßȯÀÚ...
´ÙÀ½±â»ç : À¯Àç¹Î ÀÇ°øÆÄÆ®Àå ¡®½Ä¾àó ÀÇ·á±â±âÀ§ À§¿ø¡¯¿¡ ÀçÀ§ÃË (2015-07-01 15:42:40)
ÀÌÀü±â»ç : ÃÖÈ«½Ä ±³¼ö, ¡®¼¼Á¾´ë¿Õ±â³ä»ç¾÷ȸ ȸÀ塯¿¡ ¼±ÀÓ (2015-06-29 14:46:23)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Overcoming BRAF and CDK4/6 inhibitor ...  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶